N. Sai kiran et al. 2022. Method Development and its Validation for Antineoplastic Agents (Ruxolitinib) by RP-HPLC. International Journal of Allied Medical Sciences and Clinical Research. 10, 2 (Jul. 2022), 268–273. DOI:https://doi.org/10.61096/ijamscr.v10.iss2.2022.268-273.